A predictive tool considering disease duration, age at disease onset, age, and Expanded Disability Status Scale score estimated patients’ risk of transition to secondary progressive multiple sclerosis ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Population health IT vendor Caradigm today unveiled at HIMSS17 the Caradigm Risk Stratification system, a patient list application that’s integrated with the vendor’s suite of systems including ...

At 12 months, 38.6 percent of patients who used the risk stratification tool and 44 percent who were in the educational control group were screened. There was no change in screening intent between the ...

Current prostate cancer (PCa) risk stratification tools perform reasonably well in predicting PCa death, but certain tools are more discriminating than others, according to results from a new study.